Michael J. Bond

703 total citations · 1 hit paper
10 papers, 496 citations indexed

About

Michael J. Bond is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Michael J. Bond has authored 10 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Hematology. Recurrent topics in Michael J. Bond's work include Protein Degradation and Inhibitors (4 papers), Ubiquitin and proteasome pathways (3 papers) and Multiple Myeloma Research and Treatments (2 papers). Michael J. Bond is often cited by papers focused on Protein Degradation and Inhibitors (4 papers), Ubiquitin and proteasome pathways (3 papers) and Multiple Myeloma Research and Treatments (2 papers). Michael J. Bond collaborates with scholars based in United States, Slovakia and Japan. Michael J. Bond's co-authors include Craig M. Crews, Ke Li, Ling Chu, Dhanusha A. Nalawansha, Saul Jaime‐Figueroa, Dennis L. Wright, Charles Giardina, Masako Nakanishi, Daniel W. Rosenberg and Michelle Yeagley and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Cancer Research.

In The Last Decade

Michael J. Bond

9 papers receiving 487 citations

Hit Papers

Targeted Degradation of Oncogenic KRAS G12C by VHL-Recrui... 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael J. Bond United States 6 458 227 101 33 22 10 496
Daniel McQuaid United States 3 465 1.0× 222 1.0× 149 1.5× 19 0.6× 22 1.0× 4 501
Yu-Gang Song China 4 440 1.0× 200 0.9× 101 1.0× 28 0.8× 20 0.9× 10 519
Frédéric Féru United States 7 396 0.9× 172 0.8× 59 0.6× 56 1.7× 35 1.6× 8 453
Caterina Ferraro United States 6 441 1.0× 199 0.9× 131 1.3× 28 0.8× 38 1.7× 10 477
Corynn Kasap United States 6 253 0.6× 115 0.5× 214 2.1× 61 1.8× 33 1.5× 12 490
Yudao Shen United States 17 1.1k 2.4× 275 1.2× 172 1.7× 36 1.1× 23 1.0× 25 1.1k
Sarah Lonergan Netherlands 10 262 0.6× 145 0.6× 169 1.7× 25 0.8× 26 1.2× 14 350
Xing Qiu China 10 361 0.8× 179 0.8× 131 1.3× 30 0.9× 33 1.5× 16 395
Inchul You United States 8 305 0.7× 129 0.6× 62 0.6× 24 0.7× 32 1.5× 11 351
Marty J. Heslin United States 5 245 0.5× 104 0.5× 37 0.4× 33 1.0× 20 0.9× 7 329

Countries citing papers authored by Michael J. Bond

Since Specialization
Citations

This map shows the geographic impact of Michael J. Bond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Bond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Bond more than expected).

Fields of papers citing papers by Michael J. Bond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Bond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Bond. The network helps show where Michael J. Bond may publish in the future.

Co-authorship network of co-authors of Michael J. Bond

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Bond. A scholar is included among the top collaborators of Michael J. Bond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Bond. Michael J. Bond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Bond, Michael J., Roman C. Sarott, Sai Gourisankar, et al.. (2025). Rewiring the Fusion Oncoprotein EWSR1::FLI1 in Ewing Sarcoma with Bivalent Small Molecules. Journal of the American Chemical Society. 147(49). 44739–44758.
2.
Bond, Michael J., et al.. (2024). Abstract 5777: Rewiring EWS/FLI1 with transcriptional chemical inducers of proximity (TCIPs). Cancer Research. 84(6_Supplement). 5777–5777. 1 indexed citations
3.
Li, Ke, et al.. (2024). Development of Ligands and Degraders Targeting MAGE-A3. Journal of the American Chemical Society. 146(36). 24884–24891. 8 indexed citations
4.
Bond, Michael J., Todd Douglas, Joshua T. Zimmer, et al.. (2022). Targeted Degradation of mRNA Decapping Enzyme DcpS by a VHL-Recruiting PROTAC. ACS Chemical Biology. 17(7). 1789–1798. 8 indexed citations
5.
Jaime‐Figueroa, Saul, et al.. (2021). Synthesis of Isoquinolones by Sequential Suzuki Coupling of 2-Halobenzonitriles with Vinyl Boronate Followed by Cyclization. The Journal of Organic Chemistry. 86(12). 8479–8488. 9 indexed citations
6.
Bond, Michael J. & Craig M. Crews. (2021). Proteolysis targeting chimeras (PROTACs) come of age: entering the third decade of targeted protein degradation. RSC Chemical Biology. 2(3). 725–742. 141 indexed citations
7.
Bond, Michael J., Ling Chu, Dhanusha A. Nalawansha, Ke Li, & Craig M. Crews. (2020). Targeted Degradation of Oncogenic KRAS G12C by VHL-Recruiting PROTACs. ACS Central Science. 6(8). 1367–1375. 313 indexed citations breakdown →
8.
Bond, Michael J., Masako Nakanishi, Santosh Keshipeddy, et al.. (2018). Spindle Assembly Disruption and Cancer Cell Apoptosis with a CLTC-Binding Compound. Molecular Cancer Research. 16(9). 1361–1372. 8 indexed citations
9.
Chopra, Avijeet, et al.. (2016). Efficient Activation of Apoptotic Signaling during Mitotic Arrest with AK301. PLoS ONE. 11(4). e0153818–e0153818. 5 indexed citations
10.
Bond, Michael J., et al.. (1982). Erythrokeratodermia variabilis in a patient followed through the first year of life.. PubMed. 30(5). 633–7. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026